We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Laura Elizabeth Lansdowne

Laura Elizabeth Lansdowne profile page

Managing Editor

 at Technology Networks


As managing editor, Laura works with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She oversees the in-house editorial team and works directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.


Education


University of Kent  

Nottingham Trent University  


Areas of Expertise



Got a Question for Laura Elizabeth Lansdowne?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 409
Article

Liquid Biopsy as an Alternative to Traditional Tissue Biopsy

Since co-founding Vortex Biosciences in 2012, Elodie Sollier-Christen, PhD has continued to be recognized for her work within the field of microfluidics, her expertise focused on the development of microfluidic devices for biological applications. Her determination to make a difference to the field of cancer diagnostics has driven her to successfully transform a microfluidic research platform in to a commercial product for liquid biopsy.
Industry Insight

Flow Technology Innovations Driving Drug Discovery Forward

Flow chemistry is playing an increasingly prominent role in drug discovery, enabling those in the field to streamline chemistry discovery and development efforts. Finding ways to reduce the time it takes to generate validated small-molecule compounds would be highly advantageous – which is exactly why scientists at Abbvie developed SWIFT.
Industry Insight

Deploying Cloud Technologies to Fight Pediatric Cancer

The St. Jude Cloud is a recently-launched online data-sharing and collaboration platform that provides access to the largest public repository of pediatric cancer genomics data. We caught up with Jinghui Zhang, PhD, from St. Jude Children’s Research Hospital to discuss the cloud and its impact on pediatric research.
News

Y Chromosome Gene Protects Men Against Aggressive Leukemia

Researchers have discovered a gene – found on the male-only Y chromosome – that protects against the development of acute myeloid leukemia (AML). This research was published in Nature Genetics.
The 3D Structure of Telomerase: Uncovering Its Role in Human Disease content piece image
Article

The 3D Structure of Telomerase: Uncovering Its Role in Human Disease

Researchers have published the first detailed picture and description of the 3-dimensional molecular structure of telomerase – a discovery that could enable better targeted drug screening and could result in more successful telomerase-related clinical therapeutics.
Article

Catching Cancer Early: How Improving Cancer Awareness Can Prevent Delayed Diagnosis

When it comes to cancer detection and diagnosis – the earlier the better. Cancer that remains undiagnosed until it is within ‘advanced’ stages is harder to treat successfully.

15-40 Connection’s mission is to empower patients and promote cancer conversation to ultimately improve cancer survival rates.
News

HEx Technology Cracks Cryptic Codes Identifying Potential Therapeutic Compounds

Researchers have developed a technology, known as ‘HEx’, that can detect natural products from fungal species, products which are usually extremely difficult to identify. This approach could be used to find natural compounds with therapeutic potential – paving the way to novel antimicrobial drugs.
Therapeutic Antibodies: Engineering and Production content piece image
Infographic

Therapeutic Antibodies: Engineering and Production

Antibodies are a rapidly growing, clinically successful type of biopharmaceutical, with more than 60 antibody-based drugs currently approved for use and marketed. This infographic highlights the different types of approved antibody drugs and gives an overview of antibody engineering and production.
Industry Insight

Biopharmaceutical Manufacturing: Creating a Robust and Productive Process

We recently spoke to Alice S. Chuck, Ph.D. Manufacturing Sciences & Technology Team Leader at Samsung BioLogics to learn more about the company and the completion of their newest facility, 'Songdo Plant No.3'. Alice discusses the key stages of biomanufacturing and highlights the importance of regulatory compliance.
8 Modern Milestones in Cancer Research content piece image
Listicle

8 Modern Milestones in Cancer Research

This list highlights 8 of the biggest milestones within the field of cancer research since the year 2000.
Advertisement